Related references
Note: Only part of the references are listed.Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic
Tomas Bryndziar et al.
CEREBROVASCULAR DISEASES (2022)
Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3-4.5 h
Chih-Hao Chen et al.
FRONTIERS IN NEUROLOGY (2022)
Time to Thrombolysis and Long-Term Outcomes in Patients With Acute Ischemic Stroke A Nationwide Study
Adelina Yafasova et al.
STROKE (2021)
Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke The ENCHANTED Trial
Zien Zhou et al.
NEUROLOGY (2021)
Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
Huaguang Zheng et al.
STROKE AND VASCULAR NEUROLOGY (2020)
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke
Shumei Man et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk and Secondary Prevention of Stroke Recurrence A Population-Base Cohort Study
Clare Flach et al.
STROKE (2020)
Low-dose versus standard-dose intravenous alteplase for octogenerian acute ischemic stroke patients: A multicenter prospective cohort study
A-Ching Chao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome
Monica Bandettini di Poggio et al.
NEUROLOGICAL SCIENCES (2019)
One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis
Amy Y. X. Yu et al.
STROKE (2019)
Impact of Functional Status on Noncardioembolic Ischemic Stroke Recurrence Within 1 Year: The Korean Stroke Cohort for Functioning and Rehabilitation Study
Min-Su Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2019)
Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up
Walter Muruet et al.
STROKE (2018)
Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
Jong S. Kim et al.
JOURNAL OF STROKE (2018)
Association Between Stroke Severity and 5-Year Mortality in Ischemic Stroke Patients with High-Grade Stenosis of Internal Carotid Artery
Wen-Yi Huang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry
Georgios Tsivgoulis et al.
JOURNAL OF NEUROLOGY (2017)
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke Secondary Analysis of the ENCHANTED Randomized Clinical Trial
Xia Wang et al.
JAMA NEUROLOGY (2017)
Early Change in Stroke Size Performs Best in Predicting Response to Therapy
Alexis Netis Simpkins et al.
CEREBROVASCULAR DISEASES (2017)
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Bart M. Demaerschalk et al.
STROKE (2016)
Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study
Thorkild Terkelsen et al.
INTERNATIONAL JOURNAL OF STROKE (2016)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
C. S. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Functional Status Three Months after the First Ischemic Stroke Is Associated with Long-Term Outcome: Data from a Community-Based Cohort
Rui Magalhaes et al.
CEREBROVASCULAR DISEASES (2014)
Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
Xiaoling Liao et al.
STROKE (2014)
Acute Ischemic Stroke and Long-Term Outcome After Thrombolysis Nationwide Propensity Score-Matched Follow-Up Study
Marie Louise Schmitz et al.
STROKE (2014)
Risk prediction of very early recurrence, death and progression after acute ischaemic stroke
I. L. Maier et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Long-term outcome in stroke patients treated with IV thrombolysis
Henrik Gensicke et al.
NEUROLOGY (2013)
Classifying Ischemic Stroke, from TOAST to CISS
Pei-Hao Chen et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Relationship Between Chronic Atrial Fibrillation and Worse Outcomes in Stroke Patients After Intravenous Thrombolysis
Raymond C. S. Seet et al.
ARCHIVES OF NEUROLOGY (2011)
Predictors of Early and Late Case-Fatality in a Nationwide Danish Study of 26 818 Patients With First-Ever Ischemic Stroke
Klaus Kaae Andersen et al.
STROKE (2011)
Feasibility and Safety of Intravenous Thrombolysis in Multiethnic Asian Stroke Patients in Singapore
Vijay K. Sharma et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2010)
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
Karsten Bruins Slot et al.
BRITISH MEDICAL JOURNAL (2008)
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset - Japan Alteplase Clinical Trial (J-ACT)
Takenori Yamaguchi et al.
STROKE (2006)
Are there inequalities in the provision of stroke care? Analysis of an inner-city stroke register
C McKevitt et al.
STROKE (2005)
Share Paper
